Skip to main content
Signal8
Launch Terminal
Chi Jeffrey profile photo

Jeffrey Chi

CIK: 0001839163

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aardvark Therapeutics, Inc. logo
AARD

Aardvark Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Aug 14, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    45K shares-
  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Jun 11, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    61K shares-
  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Feb 14, 2025
    Conversion(C)
    Indirect
    133.4K shares-

1-3 of 3

About Chi Jeffrey

Chi Jeffrey (SEC CIK 0001839163) files insider reports with the SEC as Director of Aardvark Therapeutics, Inc. (AARD).

Signal8 holds 4 ownership filings by Chi Jeffrey (1 Form 3, 3 Form 4), filed between Feb 12, 2025 and Aug 21, 2026. Those filings report 3 transactions, from Feb 14, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chi Jeffrey's filings is in SAN DIEGO, CA.

Recent filings by Chi Jeffrey

  • Aug 14, 2026: Grant or award of AARD derivative securities (Form 4, code A).
  • Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).
  • Feb 14, 2025: Conversion of AARD shares (Form 4, code C).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

How to read Form 4 transaction codes